IMC Chicago
ACAD icon

IMC Chicago’s Acadia Pharmaceuticals ACAD Stock Holding History

IMC Chicago’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$354K Buy
+14,000
New +$308K ﹤0.01% 5036
2026
Q1 		– Sell
-10,200
Closed -$272K – 5677
2025
Q4 		$272K Buy
+10,200
New +$244K ﹤0.01% 3859

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

IMC Chicago's ACAD Position: Q2 2026 in Review

IMC Chicago opened a new position in Acadia Pharmaceuticals (ACAD) in Q2 2026: 8,959 shares worth $227K. The stake represents ﹤0.01% of the portfolio and ranks #5548 among its holdings.

354 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • IMC Chicago held 8,959 shares of Acadia Pharmaceuticals worth $227K as of Q2 2026.
  • Acadia Pharmaceuticals was a new IMC Chicago position in Q2 2026.
  • Acadia Pharmaceuticals made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #5548 holding.
  • 354 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.